Literature DB >> 23201340

Ginkgolide B preconditioning on astrocytes promotes neuronal survival in ischemic injury via up-regulating erythropoietin secretion.

Xiaomei Wu1, Cheng Zhou, Fang Du, Yapeng Lu, Bin Peng, Lei Chen, Li Zhu.   

Abstract

Although ischemic preconditioning (IP) can provide powerful protection on brain against ischemic insult, it is rarely used in clinic to prevent the occurrence of ischemic stroke because of safety concerns. It is therefore necessary to seek the safer stimuli to initiate pharmacological preconditioning. Our previous work demonstrated that ginkgolide B (GB) could protect neurons against ischemia-induced apoptosis. Astrocytes are the most numerous cells in mammalian central nervous system and there is a close bi-directional communication between neurons and astrocytes in brain. Besides neurons, whether GB can exert the role of preconditioning on astrocytes through which to further improve neuronal survival under ischemic condition is not yet known. In the present study, primary cultured astrocytes were treated with GB for 24h or short-term ischemia (ischemia for 3h, as ischemic preconditioning/IP), and then cultured back to normoxia and normal medium for 24h to induce the preconditioning response. Astrocyte-conditioned medium (ACM) was then collected and used to incubate the cultured neurons for 24h before neurons were subjected to severe ischemia. Our results demonstrated that not only GB and IP increased astrocytic viability in ischemia, but also the conditioned medium from astrocytes treated with GB or IP increased cell viability and decreased the number of apoptosis of neurons in ischemia. We also found that GB and IP significantly stimulated astrocytes to express and secrete erythropoietin (EPO) into ACM, and the addition of anti-EPO antibody blocked the protective effect of GB or IP-treated astrocytes culture medium on neurons in ischemia. Further study of above protection revealed that ACM from astrocytes treated with GB or IP induced the inactivation of proapoptotic factor Bad by phosphorylation at serine 136 and 112 ((136)p-Bad and (112)p-Bad) in neurons. Together, our results suggest that GB is capable of preconditioning on astrocytes as IP and then protects neurons against ischemia-induced apoptosis, which is mediated by EPO. Crown
Copyright © 2012. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23201340     DOI: 10.1016/j.neuint.2012.11.007

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  12 in total

Review 1.  Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke.

Authors:  Zhongwu Liu; Michael Chopp
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

2.  Identification of ginkgolide targets in brain by photoaffinity labeling.

Authors:  Akira Kawamura; Ilyas Washington; Doina M Mihai; Francesca Bartolini; Gregg G Gundersen; Milica Tesic Mark; Koji Nakanishi
Journal:  Chem Biol Drug Des       Date:  2016-11-10       Impact factor: 2.817

3.  Ginkgolide B Protects Neurons from Ischemic Injury by Inhibiting the Expression of RTP801.

Authors:  Xiaomei Wu; Jianyou Su; Lei Chen; Baodong Ma; Xiaosu Gu; Li Zhu
Journal:  Cell Mol Neurobiol       Date:  2015-04-14       Impact factor: 5.046

4.  Ginkgolide B protects human umbilical vein endothelial cells against xenobiotic injuries via PXR activation.

Authors:  Tao Zhou; Wen-ting You; Zeng-chun Ma; Qian-de Liang; Hong-ling Tan; Cheng-rong Xiao; Xiang-lin Tang; Bo-li Zhang; Yu-guang Wang; Yue Gao
Journal:  Acta Pharmacol Sin       Date:  2016-01-18       Impact factor: 6.150

Review 5.  Neuroprotection by astrocytes in brain ischemia: importance of microRNAs.

Authors:  Yi-Bing Ouyang; Lijun Xu; Sibiao Yue; Siwei Liu; Rona G Giffard
Journal:  Neurosci Lett       Date:  2013-11-19       Impact factor: 3.046

6.  The synergistic effects of heat shock protein 70 and ginsenoside Rg1 against tert-butyl hydroperoxide damage model in vitro.

Authors:  Dan Lu; Anding Xu; Hongcheng Mai; Jiayi Zhao; Chanjuan Zhang; Renbin Qi; Huadong Wang; Daxiang Lu; Lihong Zhu
Journal:  Oxid Med Cell Longev       Date:  2015-01-15       Impact factor: 6.543

7.  Ginkgolide C Suppresses Adipogenesis in 3T3-L1 Adipocytes via the AMPK Signaling Pathway.

Authors:  Chian-Jiun Liou; Xuan-Yu Lai; Ya-Ling Chen; Chia-Ling Wang; Ciao-Han Wei; Wen-Chung Huang
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-30       Impact factor: 2.629

Review 8.  The neuroprotective mechanisms of ginkgolides and bilobalide in cerebral ischemic injury: a literature review.

Authors:  Zili Feng; Qian Sun; Wang Chen; Yu Bai; Daihua Hu; Xin Xie
Journal:  Mol Med       Date:  2019-12-21       Impact factor: 6.354

9.  Pulsed Electromagnetic Fields Stimulate HIF-1α-Independent VEGF Release in 1321N1 Human Astrocytes Protecting Neuron-Like SH-SY5Y Cells from Oxygen-Glucose Deprivation.

Authors:  Fabrizio Vincenzi; Silvia Pasquini; Stefania Setti; Simona Salati; Ruggero Cadossi; Pier Andrea Borea; Katia Varani
Journal:  Int J Mol Sci       Date:  2020-10-28       Impact factor: 5.923

Review 10.  Ginkgo Biloba Extract in Ophthalmic and Systemic Disease, With a Focus on Normal-Tension Glaucoma.

Authors:  Margarita Labkovich; Erica B Jacobs; Siddharth Bhargava; Louis R Pasquale; Robert Ritch
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2020 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.